ARCUTIS BIOTHERAPEUTIC
11.01
26-十一月-24 11:01:49
15 分钟延时
股票
+0.24
+2.18%
今日范围
10.57 - 11.50
ISIN
N/A
来源
NASDAQ
-
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
22 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
09 7月 2024 15:53:01 条件 Nasdaq GlobeNewswire
-
Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis
09 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 7月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 6月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
03 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
14 5月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 5月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
29 4月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Appoints David Topper as Chief Financial Officer
10 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
11 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
09 3月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 3月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
04 3月 2024 15:00:00 条件 Nasdaq GlobeNewswire